AdvanDx Gets FDA OK for Faster Staphylococcus Dx | GenomeWeb

NEW YORK (GenomeWeb News) – Molecular diagnostics firm AdvanDx said today that it has received US Food and Drug Administration clearance for faster versions of its Staphylococcus aureus and S. aureus/coagulase-negative Staphylococci diagnostic tests.

The new versions of the tests, which use peptide nucleic acid fluorescence in situ hybridization (PNA FISH), take 90 minutes to provide results instead of 2.5 hours for conventional tests because PNA probe hybridization is reduced from 90 minutes to 30 minutes, AdvanDx said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variant protective against Alzheimer's disease, effect of whole-genome duplication on methylation in rice, and more.

Genome editing is also bringing up questions when applied to farm animals, the New York Times reports.

Through a transcriptome study, researchers home in on the activity of inflammation-linked genes in chronically lonely people.

Determining who is and is not an author and where a researcher should fall on a list of authors can be a tricky task, Nature News writes.